Tag: Xencor Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Xencor Inc.

Biocytogen Enters into RenMab™/RenLite™ Licensing Agreement with Xencor

Added to Collection on: 2020-12-07 15:45:00

Tags for this article:

Medical specialties

Immunology

Clinical medicine

Bispecific monoclonal antibody

Biocytogen Boston Corp

Xencor Inc.

Click the tags to see associated articles and topics

View Article Details

Xencor Inks Licensing Agreement with Janssen Biotech

Added to Collection on: 2020-12-08 11:39:47

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Xencor and MD Anderson Enter Strategic Collaboration to Develop Novel T Cell-Engaging ...

Added to Collection on: 2021-01-06 21:11:15

Tags for this article:

Bispecific monoclonal antibody

Click the tags to see associated articles and topics

View Article Details

Xencor to Present at Upcoming Investor Conferences

Added to Collection on: 2021-02-04 21:22:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Xencor to Present at the Barclays Global Healthcare Conference

Added to Collection on: 2021-03-03 21:33:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

Added to Collection on: 2021-04-14 10:52:30

Tags for this article:

Bispecific monoclonal antibody

Bio-Techne Corporation

Click the tags to see associated articles and topics

View Article Details

INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce ...

Added to Collection on: 2021-06-14 20:02:22

Tags for this article:

Medical specialties

Clinical medicine

Monoclonal antibodies

Tumor necrosis factor

Forward-looking statement

Neuroinflammation

INmune Bio Inc.

Xencor Inc.

Click the tags to see associated articles and topics

View Article Details

Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Buy" from Analysts

Added to Collection on: 2021-06-19 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Local Companies See Gains in Covid Vaccine Development

Added to Collection on: 2021-06-21 06:56:15

Tags for this article:

Deployment of COVID-19 vaccines

ImmunityBio COVID-19 vaccine

Bristol Myers Squibb Co

Xencor Inc.

Click the tags to see associated articles and topics

View Article Details

Xencor (NASDAQ:XNCR) Downgraded by StockNews.com - Defense World

Added to Collection on: 2024-03-01 13:43:48

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Tag: Xencor Inc.

Recent Related Articles to Xencor Inc.

Biocytogen Enters into RenMab™/RenLite™ Licensing Agreement with Xencor

Xencor Inks Licensing Agreement with Janssen Biotech

Xencor and MD Anderson Enter Strategic Collaboration to Develop Novel T Cell-Engaging ...

Xencor to Present at Upcoming Investor Conferences

Xencor to Present at the Barclays Global Healthcare Conference

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce ...

Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Buy" from Analysts

Local Companies See Gains in Covid Vaccine Development

Xencor (NASDAQ:XNCR) Downgraded by StockNews.com - Defense World

Create dashboard for Tag: Xencor Inc.